ArticleFrontiers in oncology2020

Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report.

Daiki Ikarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.